Nivolumab induced morphea

G Ital Dermatol Venereol. 2020 Oct;155(5):701-702. doi: 10.23736/S0392-0488.18.06118-7. Epub 2018 Oct 3.

Authors

Giacomo Dal Bello¹, Paolo Rosina², Chiara Colato³, Giampiero Girolomoni²

Affiliations

¹ Section of Dermatology, Department of Medicine, University of Verona, Verona, Italy - giacomo.dalbello@studenti.univr.it.
² Section of Dermatology, Department of Medicine, University of Verona, Verona, Italy.
³ Section of Pathology, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.

PMID: 30295447
DOI: 10.23736/S0392-0488.18.06118-7

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Drug Eruptions / etiology*
Female
Humans
Immune Checkpoint Inhibitors / adverse effects*
Nivolumab / adverse effects*
Scleroderma, Localized / chemically induced*

Substances

Immune Checkpoint Inhibitors
Nivolumab